Skip to content
Acting Auditions – Lifestyle
Author:
Recursion Pharmaceuticals
Recursion Announces Sanofi Options Potential First-in-Class Immunology Development Candidate from Their Collaboration
October 15, 2026
Recursion Announces Pricing of $200 Million Underwritten Offering of Class A Common Stock
October 15, 2026
Recursion Announces $200 Million Oversubscribed Follow-On Offering, Clinical Data Updates, and Partnership Milestone
October 15, 2026
Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program
August 5, 2026
Recursion to Participate in Upcoming Investor Conferences
August 4, 2026
Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules
July 31, 2026
Recursion to Report Second Quarter 2026 Business Updates and Financial Results on August 5th
July 29, 2026
Recursion to Participate in Upcoming Investor Conferences
June 2, 2026
Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules
May 29, 2026
Recursion Reports First Quarter Financial Results and Provides Business Update
May 7, 2026
1
2
Next Page
→